Informatie:
Fout:
ID
42266
Beschrijving
Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin); ODM derived from: https://clinicaltrials.gov/show/NCT00890006
Link
https://clinicaltrials.gov/show/NCT00890006
Trefwoorden
Versies (3)
- 13-05-17 13-05-17 -
- 10-04-21 10-04-21 - Ahmed Rafee, MD
- 26-04-21 26-04-21 - Sarah Riepenhausen
Houder van rechten
MDM
Geüploaded op
26 april 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006
Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006
- StudyEvent: Eligibility
Similar models
Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
localized prostate cancer
Item
low or intermediate risk localized prostate cancer:
boolean
C0600139 (UMLS CUI [1])
gleason score
Item
gleason score ≤ 7
boolean
C0332326 (UMLS CUI [1])
psa
Item
psa <20
boolean
C0138741 (UMLS CUI [1])
prostate cancer stage
Item
stage t2a or less (stage 2 only)
boolean
C0280280 (UMLS CUI [1])
prostate cancer biopsy histology
Item
<50% of biopsy cores involved with tumor (stage 2 only)
boolean
C0600139 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
C0005558 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
hip replacement
Item
history of hip replacement
boolean
C0392806 (UMLS CUI [1])
inflammatory bowel disease, collagen vascular disease
Item
inflammatory bowel disease or collagen vascular disease
boolean
C0021390 (UMLS CUI [1])
C0262428 (UMLS CUI [2])
C0262428 (UMLS CUI [2])
fiducial markers contraindication
Item
contraindication to fiducial marker placement
boolean
C2826325 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,2])
bleeding diathesis, anticoagulant therapy
Item
bleeding diathesis or anticoagulant therapy that cannot safely be ceased temporarily
boolean
C0005779 (UMLS CUI [1])
C0150457 (UMLS CUI [2])
C0150457 (UMLS CUI [2])
trus- guided prostate biopsy adverse event
Item
severe adverse event with prior trus-guided prostate biopsy
boolean
C0194804 (UMLS CUI [1,1])
C0373345 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0373345 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
patient refuses fiducial markers
Item
patient refuses fiducial marker placement
boolean
C2826325 (UMLS CUI [1,1])
C3242233 (UMLS CUI [1,2])
C3242233 (UMLS CUI [1,2])
mri contraindication
Item
contraindication to mri
boolean
C0024485 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
C0522473 (UMLS CUI [1,2])
patient randomization
Item
patient randomization in profit trial (stage 2 only)
boolean
C0030705 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
C0034656 (UMLS CUI [1,2])
prostate radiotherapy
Item
patients not prescribed 78gy in 39 fractions to the prostate gland.
boolean
C0948317 (UMLS CUI [1])